SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
vation
Lv1
1
50 积分
2022-03-04 加入
最近求助
最近应助
互助留言
Efficacy and Safety of Admilparant, an LPA1 Antagonist in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial
5天前
已完结
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
5天前
已完结
A Novel Inhalable Nanobody Targeting IL-4Rα for the Treatment of Asthma
2个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
5个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
5个月前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
6个月前
已完结
Xevinapant combined with pembrolizumab in patients with advanced, pretreated colorectal and pancreatic cancer: results of the phase 1b/2 CATRIPCA trial
6个月前
已完结
A researcher’s guide to preclinical mouse NASH models
6个月前
已完结
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design
8个月前
已完结
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design
10个月前
已完结
没有进行任何应助
感谢,点赞,帮大忙了,么么哒
5个月前
感谢,点赞,速度真快,帮大忙了,么么哒
1年前
感谢,点赞,速度真快,帮大忙了,么么哒
2年前
感谢,点赞,速度真快,帮大忙了,么么哒
2年前
感谢,点赞,速度真快,帮大忙了,么么哒
2年前
感谢,点赞,速度真快,帮大忙了,么么哒
2年前
感谢,点赞,速度真快,帮大忙了,么么哒
2年前
感谢,点赞,速度真快,帮大忙了,么么哒
2年前
速度真快,帮大忙了,么么哒
2年前
速度真快,么么哒
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论